Our Chief Scientific Officer, Adele Rowley, will be in London on 18 February for this year’s Ace Drug Discovery Summit, where she will be giving a presentation titled “Allosteric modulation of long-form PDE4 enzymes, a novel disease modifying treatment for Autosomal Dominant Polycystic Kidney Disease” at 2.30pm GMT.
At Mironid, we are dedicated to revolutionising treatment options for patients with ADPKD and other rare kidney diseases, and we’re excited to share our latest advancements at this event!
Allosteric modulation of long-form PDE4 enzymes, a novel disease modifying treatment for Autosomal Dominant Polycystic Kidney Disease
